Fierce Biotech August 11, 2022
A study of Abbott’s rapid, portable blood test for evaluating concussions showed that by taking a sample on the day of a traumatic brain injury, the presence of certain biomarkers could help predict how well a patient will recover in the weeks ahead.
By testing a patient as soon as possible, clinicians may be able to spot proteins from the brain that help paint a more accurate picture of a TBI and its potential for causing long-term complications, comas or death, the company said.
“Brain injury biomarkers will one day be the standard of care to evaluate and treat patients,” Fred Korley, first author of the study published in The Lancet Neurology,...
Today's Sponsors
Today's Sponsor